Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Immunologic Deficiency Syndromes × plerixafor × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Warts 1 Neutropenia 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Leukopenia 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Infections 1 Immunologic Deficiency Syndromes 1 Hematologic Neoplasms 1 Agammaglobulinemia 1 Acquired Immunodeficiency Syndrome 1

Interventions

plerixafor 1 Holistic Health 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00967785 2026-03-09

A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

National Institutes of Health Clinical Center (CC)

Phase 1/2 Recruiting

Agammaglobulinemia, Immunologic Deficiency Syndromes, Infections, Leukopenia, Neutropenia, Warts

Data powered by HemOnc (CC BY 4.0) Colophon ⚡